State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, 1295 Ding-Xi Road, Shanghai, China
E-mail: email@example.com; Fax: +86 21 52413122
; Tel: +86 21 52412714
J. Mater. Chem., 2011,21, 5845-5855
09 Nov 2010,
11 Jan 2011
First published online
24 Feb 2011
The biomedical applications of mesoporous silicananoparticles (MSNs) as efficient drug delivery carriers have attracted great attention in the last decade. The structure, morphology, size, and surface properties of MSNs have been found to be facilely tunable for the purposes of drug loading, controlled drug release and delivery, and multifuctionalization. Meanwhile, the biosafety and in vivodrug efficiency of MSN-based nano drug delivery systems (nano-DDSs), involving biocompatibility (including cytotoxicity, blood and tissue compatibility) and pharmacokinetics (including biodistribution, biodegradation, retention, excretion, blood circulation) are also drawing increasing attention because of their clinical application prospects. Herein, we review the most recent research progresses on the synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility of MSNs.
Fetching data from CrossRef. This may take some time to load.
This may take some time to load.
Journal of Materials Chemistry
- Information Point